Actively Recruiting
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
Led by Boryung Pharmaceutical Co., Ltd · Updated on 2025-12-04
1000
Participants Needed
1
Research Sites
212 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to comprehensively identify the various treatment patterns of second- or subsequent-line palliative chemotherapy used in patients with metastatic colorectal cancer who have experienced failure of first-line palliative chemotherapy and to evaluate the prognosis of each treatment.
CONDITIONS
Official Title
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have signed informed consent after learning about the study's purpose and methods
- Patients with histologically and radiologically confirmed metastatic colorectal cancer with measurable lesions
- Patients scheduled to receive their first second-line palliative chemotherapy after failure of first-line treatment or relapse within 6 months after finishing postoperative adjuvant therapy
- Patients who understand the study, cooperate with the process, and can participate until the study ends
You will not qualify if you...
- Female patients who are pregnant, breastfeeding, or have childbearing potential
- Patients who have used an investigational product within 4 weeks before enrollment or plan to join another clinical trial during this study
- Patients considered unsuitable for participation by the investigator's judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, South Korea
Actively Recruiting
Research Team
S
Shinyoung Oh
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here